Bugianesi E - Search Results

1

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.

Pelusi S, Petta S, Rosso C, Borroni V, Fracanzani AL, Dongiovanni P, Craxi A, Bugianesi E, Fargion S, Valenti L. Pelusi S, et al. Among authors: bugianesi e. PLoS One. 2016 Sep 20;11(9):e0163069. doi: 10.1371/journal.pone.0163069. eCollection 2016. PLoS One. 2016. PMID: 27649410 Free PMC article.

2

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Marchesini G, et al. Among authors: bugianesi e. Diabetes. 2001 Aug;50(8):1844-50. doi: 10.2337/diabetes.50.8.1844. Diabetes. 2001. PMID: 11473047

3

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.

Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G. Bugianesi E, et al. Am J Gastroenterol. 2005 May;100(5):1082-90. doi: 10.1111/j.1572-0241.2005.41583.x. Am J Gastroenterol. 2005. PMID: 15842582 Clinical Trial.

4

Nonalcoholic fatty liver disease and the metabolic syndrome.

Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Marchesini G, et al. Among authors: bugianesi e. Curr Opin Lipidol. 2005 Aug;16(4):421-7. doi: 10.1097/01.mol.0000174153.53683.f2. Curr Opin Lipidol. 2005. PMID: 15990591 Review.

5

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S. Valenti L, et al. Among authors: bugianesi e. Am J Gastroenterol. 2007 Jun;102(6):1251-8. doi: 10.1111/j.1572-0241.2007.01192.x. Epub 2007 Mar 27. Am J Gastroenterol. 2007. PMID: 17391316

6

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S. Fracanzani AL, et al. Among authors: bugianesi e. Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429. Hepatology. 2008. PMID: 18752331

7

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S. Valenti L, et al. Among authors: bugianesi e. Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18. Gastroenterology. 2010. PMID: 19931264 Free article.

8

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.

Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, Gasbarrini A, Loguercio C, Lonardo A, Marchesini G, Marra F, Persico M, Prati D, Baroni GS; NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato. Loria P, et al. Among authors: bugianesi e. Dig Liver Dis. 2010 Apr;42(4):272-82. doi: 10.1016/j.dld.2010.01.021. Epub 2010 Feb 19. Dig Liver Dis. 2010. PMID: 20171943

9

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Valenti L, et al. Among authors: bugianesi e. Hepatology. 2010 Apr;51(4):1209-17. doi: 10.1002/hep.23622. Hepatology. 2010. PMID: 20373368

10

Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study.

Valenti L, Moscatiello S, Vanni E, Fracanzani AL, Bugianesi E, Fargion S, Marchesini G. Valenti L, et al. Among authors: bugianesi e. QJM. 2011 Feb;104(2):141-9. doi: 10.1093/qjmed/hcq170. Epub 2010 Sep 17. QJM. 2011. PMID: 20851820 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page